Author:
Kenney Patrick A.,Wood Christopher G.
Reference127 articles.
1. N H, Noone A, Kraphcho M, Neyman N, editors. SEER cancer statistics review, 1975–2008 [Internet]. 2011 [cited 2011 Dec. 7]; Available from:
http://seer.cancer.gov/csr/1975_2008/
.
2. Bex A, Jonasch E, Kirkali Z, et al. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol. 2010;58(6):819–28.
3. Jacobsohn K, Wood C. Adjuvant therapy for renal cell carcinoma. Semin Oncol. 2006;33(5):576–82.
4. Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res. 2007;13(2 Pt 2):697s–702.
5. Cindolo L, la Taille de A, Messina G, et al. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int. 2003;92(9):901–5.